The Underside Of Intra-Cellular Therapies Inc (ITCI) Stock Is A Little Uncertain

Robert W. Baird raised the price target for the Intra-Cellular Therapies Inc (NASDAQ:ITCI) stock to “an Outperform”. The rating was released on January 03, 2024, according to finviz. The research report from Morgan Stanley has initiated the stock to Overweight, with a price target set at $80. The stock was downgraded by Goldman, who disclosed […]

Why Intra-Cellular Therapies Inc (NASDAQ:ITCI) Stock down -8.61% in Last Week?

Robert W. Baird raised the price target for the Intra-Cellular Therapies Inc (NASDAQ:ITCI) stock to “an Outperform”. The rating was released on January 03, 2024, according to finviz. The research report from Morgan Stanley has initiated the stock to Overweight, with a price target set at $80. The stock was downgraded by Goldman, who disclosed […]

Intra-Cellular Therapies Inc (ITCI) Stock: Pessimism is a stepping stone to opportunity

Robert W. Baird raised the price target for the Intra-Cellular Therapies Inc (NASDAQ:ITCI) stock to “an Outperform”. The rating was released on January 03, 2024, according to finviz. The research report from Morgan Stanley has initiated the stock to Overweight, with a price target set at $80. The stock was downgraded by Goldman, who disclosed […]

Yummy or too sour? Intra-Cellular Therapies Inc (ITCI) Stock

Robert W. Baird raised the price target for the Intra-Cellular Therapies Inc (NASDAQ:ITCI) stock to “an Outperform”. The rating was released on January 03, 2024, according to finviz. The research report from Morgan Stanley has initiated the stock to Overweight, with a price target set at $80. The stock was downgraded by Goldman, who disclosed […]

A positive surprise is on the way: Intra-Cellular Therapies Inc (ITCI) Stock

Robert W. Baird raised the price target for the Intra-Cellular Therapies Inc (NASDAQ:ITCI) stock to “an Outperform”. The rating was released on January 03, 2024, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as […]

Intra-Cellular Therapies Inc (ITCI) Stock at a key inflection point

Robert W. Baird raised the price target for the Intra-Cellular Therapies Inc (NASDAQ:ITCI) stock to “an Outperform”. The rating was released on January 03, 2024, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as […]